SCHEMBL8445207

SCHEMBL8445207

C=Cc1cc(-c2ccccc2)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.41
ALDH1A1 P00352 4/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
TSHR P16473 1/20 0.37
CYP2E1 P05181 1/20 0.37
CYP2A6 P11509 1/20 0.37
CYP2B6 P20813 1/20 0.37
NOTUM Q6P988 1/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
KMT2A Q03164 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27708181 0.78 HDAC6 (0.41) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1
SCHEMBL379478 0.78 HDAC6 (0.44) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1
SCHEMBL15314018 0.75 HDAC6 (0.39) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1
SCHEMBL2600074 0.75 HDAC6 (0.39) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1
SCHEMBL28933424 0.74 HDAC6 (0.45) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1
SCHEMBL7014691 0.72 CYP11B1 (0.42) HDAC6ALDH1A1CYP11B1CYP11B2TSHR
SCHEMBL22022356 0.71 HDAC6 (0.36) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1
SCHEMBL7017974 0.71 TOP1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7915311 0.70 HSD17B1 (0.61) HDAC6ALDH1A1CYP2E1CYP2A6CYP2B6
SCHEMBL927627 0.68 ALDH1A1 (0.44) HDAC6ALDH1A1CYP11B1CYP11B2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040014801-A1 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014801-A1 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use CTSB, CTSS, CTSL HDAC6 366/4885ALDH1A1 1366/4885CYP11B1 1673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.